Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
1 mg
5 mg
10 mg
1 mM
2.2394 mL
11.1972 mL
22.3944 mL
5 mM
0.4479 mL
2.2394 mL
4.4789 mL
10 mM
0.2239 mL
1.1197 mL
2.2394 mL
50 mM
0.0448 mL
0.2239 mL
0.4479 mL
Description
Erdafitinib (JNJ-42756493) is a potent and selective orally bioavailable, pan inhibitor with potential antineoplastic activity. Erdafitinib also binds to , , , , and and induces cellular .
Targets
In vitro
JNJ-42756493 is a potent, oral pan-FGFR tyrosine kinase inhibitor with half-maximal inhibitory concentration values in the low nanomolar range for all members of the FGFR family (FGFR1 to FGFR4), with minimal activity on vascular endothelial growth factor receptor (VEGFR) kinases compared with FGFR kinases (approximately 20-fold potency difference). In vitro, the proliferation of cells treated with JNJ-42756493 is decreased, associated with increased apoptotic death and decreased cell survival.
